{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:21:27Z","timestamp":1781130087093,"version":"3.54.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Isoniazid (INH), a first-line drug for tuberculosis, exerts bactericidal effects through inhibition of mycolic acid synthesis. However, its potential to modulate host immunity remains unclear. Reactive oxygen species (ROS) are critical antimicrobial effectors produced by innate immune cells, and their regulation is essential for effective immune signalling and pathogen clearance, whereas excessive ROS can contribute to inflammation and tissue damage. This duality makes it important to determine whether INH modifies ROS production in innate immune cells, particularly in individuals with latent infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We investigated whether INH affects ROS production in circulating immune cells and plasma cytokines in healthy controls and LTBI individuals before treatment initiation (n = 9 per group). Whole blood was incubated with INH at plasma concentrations observed in humans (2, 4.5, and 10.5\u00a0\u03bcg\/mL). Intracellular ROS production in neutrophils, eosinophils, and monocytes was quantified using flow cytometry with the oxidation-sensitive probe DHR-123, following stimulation with fMLP,\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      , or PMA. IL-1\u03b2, IL-6, IL-8, TNF, IFN-\u03b3, IL-10, and TGF-\u03b21 were measured in INH-exposed unstimulated blood by cytometric bead array.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In healthy controls, INH induced a significant reduction in ROS production in monocytes (median values of DHR+ classical monocytes after\n                      <jats:italic>E. coli<\/jats:italic>\n                      stimulation with 0\u00a0\u03bcg\/mL INH were 26.2%, 2\u00a0\u03bcg\/mL INH 19.9% (p &amp;lt; 0.05), 4.5\u00a0\u03bcg\/mL INH 16.2% (p &amp;lt; 0.01), and 10.5\u00a0\u03bcg\/mL INH 16.3% (p &amp;lt; 0.01)). In contrast, INH had no effect on ROS production in LTBI individuals, who overall displayed significantly lower ROS responses to stimulation compared with healthy controls, particularly in\n                      <jats:italic>E. coli<\/jats:italic>\n                      -stimulated eosinophils (p &amp;lt; 0.0001 all data \u00b1 INH aggregated) and PMA-stimulated classical monocytes (p &amp;lt; 0.0001 all data \u00b1 INH aggregated). INH did not alter cytokine levels in unstimulated blood after 24\u00a0h.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>These findings suggest that INH dose-dependently downregulates monocyte ROS production in healthy individuals, whereas LTBI individuals exhibit an diminished ROS response compared to healthy controls that is not further affected by INH. This work provides new insight into the immunomodulatory properties of INH and highlights the need to consider host responses, such as ROS production, in optimizing TB treatment and adjunctive therapy development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1763287","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:33:34Z","timestamp":1774935214000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential regulation of monocyte oxidative burst by isoniazid in healthy and latent tuberculosis-infected subjects"],"prefix":"10.3389","volume":"17","author":[{"given":"Josephine","family":"Gal","sequence":"first","affiliation":[{"name":"Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"S\u00f6nnerbrandt","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Link\u00f6ping University Hospital and Kalmar County Hospital, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Braian","sequence":"additional","affiliation":[{"name":"Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]},{"name":"Department of Infectious Diseases, Link\u00f6ping University Hospital and Kalmar County Hospital, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sch\u00f6n","sequence":"additional","affiliation":[{"name":"Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]},{"name":"Department of Infectious Diseases, Link\u00f6ping University Hospital and Kalmar County Hospital, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Blomgran","sequence":"additional","affiliation":[{"name":"Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Link\u00f6ping University","place":["Link\u00f6ping, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1244556","DOI":"10.3389\/fimmu.2023.1244556","article-title":"Initial immune response after exposure to Mycobacterium tuberculosis or to SARS-COV-2: similarities and differences","volume":"14","author":"Aiello","year":"2023","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1084\/jem.20181776","article-title":"A major role for ferroptosis in mycobacterium tuberculosis\u2013induced cell death and tissue necrosis","volume":"216","author":"Amaral","year":"2019","journal-title":"J. Exp. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e20220504","DOI":"10.1084\/jem.20220504","article-title":"GPX4 regulates cellular necrosis and host resistance in Mycobacterium tuberculosis infection","volume":"219","author":"Amaral","year":"2022","journal-title":"J. Exp. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.it.2025.02.009","article-title":"Oxidative battles in tuberculosis: walking the ferroptotic tightrope","volume":"46","author":"Ara\u00fajo-Pereira","year":"2025","journal-title":"Trends Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1042\/CS20150021","article-title":"Diverging biological roles among human monocyte subsets in the context of tuberculosis infection","volume":"129","author":"Balboa","year":"2015","journal-title":"Clin. Sci."},{"key":"B6","first-page":"E9","article-title":"The history of tuberculosis: from the first historical records to the isolation of Koch\u2019s bacillus","volume":"58","author":"Barberis","year":"2017","journal-title":"J. Prev. Med. Hyg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcimb.2020.00493","article-title":"Understanding and exploiting the effect of tuberculosis antimicrobials on host mitochondrial function and bioenergetics","volume":"15","author":"Cahill","year":"2020","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-3-031-35139-6_6","article-title":"Sex and gender differences in tuberculosis pathogenesis and treatment outcomes","volume-title":"Sex and gender differences in infection and treatments for infectious diseases","author":"Dabitao","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.chom.2017.09.003","article-title":"tuberculosis-induced necrosis of infected neutrophils promotes bacterial growth following phagocytosis by macrophages","volume":"22","author":"Dallenga","year":"2017","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0022-5347(17)36973-2","article-title":"Impaired immune response by isoniazid treatment during intravesical BCG administration in the Guinea pig","volume":"148","author":"De Boer","year":"1992","journal-title":"J. Urol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/10408347.2017.1281098","article-title":"A review of characteristics, properties and analytical methods","volume":"47","author":"dos Santos","year":"2017","journal-title":"Crit. Rev. Anal. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/cpt.180","article-title":"Optimizing the clinical pharmacology of tuberculosis medications","volume":"98","author":"Egelund","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1462-5822.2009.01335.x","article-title":"Mycobacterial survival strategies in the phagosome: defence against host stresses","volume":"11","author":"Ehrt","year":"2009","journal-title":"Cell Microbiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.tube.2006.04.001","article-title":"Understanding the action of INH on a highly INH-Resistant Mycobacterium tuberculosis strain using genechips","volume":"87","author":"Fu","year":"2007","journal-title":"Tuberculosis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1164\/rccm.202103-0534OC","article-title":"A semimechanistic model of the bactericidal activity of high-dose isoniazid against multidrug-resistant tuberculosis: results from a randomized clinical trial","volume":"204","author":"Gausi","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/antiox10101572","article-title":"Oxidative stress and inflammatory mediators in exhaled breath condensate of patients with pulmonary tuberculosis. A pilot study with a biomarker perspective","volume":"10","author":"Guzm\u00e1n-Beltr\u00e1n","year":"2021","journal-title":"Antioxidants"},{"key":"B16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fcimb.2023.1146571","article-title":"Mechanisms of lung damage in tuberculosis: implications for chronic obstructive pulmonary disease","volume":"21","author":"Kayongo","year":"2023","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.dib.2016.01.035","article-title":"Global protein expression dataset acquired during isoniazid-induced cytoprotection against H2O2 challenge in HL-60 cells","volume":"6","author":"Khan","year":"","journal-title":"Data Brief."},{"key":"B18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cbi.2015.11.026","article-title":"Cytoprotective effect of isoniazid against H2O2 derived injury in HL-60 cells","volume":"244","author":"Khan","year":"","journal-title":"Chem. Biol. Interact."},{"key":"B19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000330442","article-title":"Anti-tuberculosis drugs and human polymorphonuclear leukocyte functions","volume":"57","author":"Kielland","year":"2011","journal-title":"Chemotherapy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.chom.2012.03.008","article-title":"Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action","volume":"11","author":"Kim","year":"2012","journal-title":"Cell Host Microbe"},{"key":"B21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1001\/jama.2022.24362","article-title":"Management of latent tuberculosis infection","volume":"329","author":"Kim","year":"2023","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e17091","DOI":"10.1371\/journal.pone.0017091","article-title":"Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice","volume":"6","author":"Koo","year":"2011","journal-title":"PLoS ONE"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1438406","DOI":"10.3389\/ftubr.2024.1438406","article-title":"The role of the immune response in developing tuberculosis infection: from latent infection to active tuberculosis","volume":"2","author":"Kudryavtsev","year":"2024","journal-title":"Front. Tuberc."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e228","DOI":"10.1016\/S1473-3099(18)30134-8","article-title":"Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions","volume":"18","author":"Menzies","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.tube.2018.09.007","article-title":"Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection","volume":"113","author":"Mohareer","year":"2018","journal-title":"Tuberculosis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00284-023-03491-x","article-title":"Latent tuberculosis: challenges in diagnosis and treatment, perspectives, and the crucial role of biomarkers","volume":"80","author":"Palanivel","year":"2023","journal-title":"Curr. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"113308","DOI":"10.1016\/j.jim.2022.113308","article-title":"Optimized flow cytometry protocol for dihydrorhodamine 123-based detection of reactive oxygen species in leukocyte subpopulations in whole blood","volume":"507","author":"Pioch","year":"2022","journal-title":"J. Immunol. Methods"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3389\/fimmu.2018.01726","article-title":"Monocyte subsets: phenotypes and function in tuberculosis infection","volume":"9","author":"Sampath","year":"2018","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/BF00571847","article-title":"Effects of isoniazid (INH) on the BCG-Induced local immune response after intravesical BCG therapy for superficial bladder cancer","volume":"22","author":"Stassar","year":"1994","journal-title":"Urol. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"30190","DOI":"10.1074\/jbc.C114.598946","article-title":"Isoniazid induces apoptosis of activated CD4+ T cells","volume":"289","author":"Tousif","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/B978-0-12-398264-3.00004-8","article-title":"Redox biology of tuberculosis pathogenesis","volume":"60","author":"Trivedi","year":"2012","journal-title":"Adv. Microb. Physiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fmicb.2011.00105","article-title":"The response of Mycobacterium tuberculosis to reactive oxygen and nitrogen species","volume":"2","author":"Voskuil","year":"2011","journal-title":"Front. Microbiol."},{"key":"B33","volume-title":"Global tuberculosis report","year":"2023"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1002\/eji.201646349","article-title":"Isoniazid-induced control of Mycobacterium tuberculosis by primary human cells requires interleukin-1 receptor and tumor necrosis factor","volume":"46","author":"Yamashiro","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"16240","DOI":"10.1038\/s41598-023-43310-8","article-title":"Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis","volume":"13","author":"Yoopetch","year":"2023","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fphar.2023.1331371","article-title":"The efficacy and safety of high-dose isoniazid-containing therapy for multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"14","author":"Zhou","year":"2024","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1763287\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:33:35Z","timestamp":1774935215000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1763287\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":37,"alternative-id":["10.3389\/fphar.2026.1763287"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1763287","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"article-number":"1763287"}}